-
Mashup Score: 5Understanding Molecular Drivers of Lymphedema - 5 month(s) ago
Northwestern Medicine scientists have uncovered molecular mechanisms underlying lymphatic valve development, a discovery which could prove useful in treating lymphedema, according to a study published in The Journal of Clinical Investigation.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 3Brain Tumor SPORE Receives $10.8 Million NCI Award Renewal - 5 month(s) ago
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University has received a renewed five-year $10.8 million Specialized Program of Research Excellence (SPORE) grant from the National Cancer Institute for the Lurie Cancer Center to advance translational research and improve outcomes for patients with brain cancer.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet-
The Lurie Cancer Center Brain Tumor SPORE, led by @maciejlesniakmd, chair of @NeurosurgeryNM, is focused on improving treatment strategies for patients with brain tumors. On #GlioblastomaAwarenessDay, learn about the impact of @theNCI-funded SPORE grant: https://t.co/JxVXZxzsQg https://t.co/oQ1OK6W2Kc
-
-
Mashup Score: 2Understanding the Role of RNA Methylation in Cancer - 6 month(s) ago
RNA modifications could serve as a therapeutic target for certain types of cancer, according to a new study published in Molecular Cell which sheds new light on the complex process underlying RNA transcription.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 2Combination Therapy May Improve Outcomes for Advanced Bladder Cancer - 6 month(s) ago
Patients with immunotherapy-resistant bladder cancer who received a novel combination treatment demonstrated improved response to treatment, according to a recent study published in Nature Medicine.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Oncologists1Tweet-
Patients with #immunotherapy-resistant #bladdercancer who received a novel combination therapy demonstrated improved response compared to standard treatment, according to a recent study in @NatureMedicine co-authored by @JoshMeeks of Lurie Cancer Center. https://t.co/h8rBGyUmzF… https://t.co/wWk1iTbSB3 https://t.co/uSGLOdRFSI
-
-
Mashup Score: 5Goyal and Kennedy Named 2024 Pew Scholars - 6 month(s) ago
Yogesh Goyal, PhD, and Ann Kennedy, PhD, have been named 2024 Pew Scholars by The Pew Charitable Trusts, which recognizes promising early-career investigators whose research will accelerate discovery and translation in the biomedical sciences.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Dysfunctional Enzyme May Lead to Liver Disease - 6 month(s) ago
A dysfunctional enzyme may lead to nonalcoholic fatty liver disease in mice, according to a study published in Science Advances.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 6Combination Therapy Shows Promise in Subset of Breast Cancers - 7 month(s) ago
Combining two cancer drugs may be a promising treatment for advanced metastatic breast cancer, according to the results of a clinical trial published in the Journal of Clinical Oncology.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 15Study Examines Surge in RSV Cases After the COVID-19 Pandemic - 7 month(s) ago
The surge in RSV cases following the COVID-19 pandemic may have been, in part, caused by increased testing and changes to the RSV genome, according to a Northwestern Medicine study published in Nature Communications.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 21New Glioblastoma Treatment Reaches Human Brain Tumor and Helps Immune Cells Recognize Cancer Cells - 7 month(s) ago
Northwestern Medicine scientists have used ultrasound technology to penetrate the blood-brain barrier and provide a small dose of a chemotherapy and immunotherapy, a major advance for the treatment of this deadly cancer.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 25New Biomarker May Predict Treatment Response in Bladder Cancer - 7 month(s) ago
Patients with metastatic urothelial cancer and increased expression of the NECTIN4 gene had a dramatically better response to antibody treatment than patients with reduced gene expression, according to recent findings published in the Journal of Clinical Oncology.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Onc News and JournalsTweet
Study findings from Lurie Cancer Center member @SusanQuaggin, MD, Chair of the Department of Medicine at @NUFeinbergMed, provide insight into the genetic regulation of lymphatic function and the molecular pathways involved in #lymphedema. https://t.co/0PVussoxDC